Pharmac

pharmac.govt.nz Imported from official source

New Zealand's medicines funding agency; funding decisions and consultation publications from its own official source.

Publications 32

  1. Antiretroviral endorsement issue

    Technical issue affecting prescriptions for emtricitabine with tenofovir disoproxil and dolutegravir

    Announcement Safety
  2. Agenda for November 2026 Pharmacology and Therapeutics advisory committee (PTAC) meeting

    Information on what the Pharmacology and Therapeutics Advisory Committee (PTAC) will be considering at its upcoming meeting in November 2026.

    Announcement Safety
  3. Agenda for November 2026 Mental Health Advisory Committee meeting

    Information on what the Mental Health Advisory Committee will be considering at its upcoming meeting in November 2026.

    Announcement
  4. Improving the assessment of medical devices

    Pharmac is strengthening how new and emerging health technologies are assessed, while ensuring the right expert advice is available to inform decision making.

    Announcement Safety
  5. Strengthening the Pharmaceutical Schedule

    Pharmac is redeveloping the Pharmaceutical Schedule to ensure it remains sustainable, reliable, and fit for purpose for the health system.

    Announcement Safety
  6. Next stage of Pharmac improvement programme underway

    Announcement
  7. Bringing funded flu vaccines forward for under 5s

    Announcement Safety
  8. Changes to support increased access to Estradiol TDP Mylan amid ongoing Estradot supply constraints

    Pharmac has made changes to support increased access to the Estradiol TDP Mylan brand of patches, to make the brand easier and more convenient to use.  

    Announcement Safety
  9. Widened access to diabetes medicines to benefit over 30,000 New Zealanders

    Pharmac has widened access to four medicines for people with type 2 diabetes.

    Announcement Safety
  10. Agenda for October 2026 Gastrointestinal Advisory Committee meeting

    Information on what the Gastrointestinal Advisory Committee will be considering at its upcoming meeting in October 2026.

    Announcement
  11. Agenda for October 2026 Cardiovascular Advisory Committee meeting

    Information on what the Cardiovascular Advisory Committee will be considering at its upcoming meeting in October 2026.

    Announcement
  12. Agenda for November 2026 Cancer Treatments (CTAC) meeting

    Information on what the Cancer Treatments Advisory Committee (CTAC) will be considering at its upcoming meeting in November 2026.

    Announcement
  13. Wegovy and Mounjaro funding status

    Medsafe has approved two new medicines as suitable to support weight management. Pharmac's role is to decide whether medicines will be publicly funded.

    Announcement Safety 3 versions
  14. Agenda for October 2026 Cancer Treatments (CTAC) meeting

    Information on what the Cancer Treatments Advisory Committee (CTAC) will be considering at its upcoming meeting in October 2026. This has been rescheduled from September due to availability.

    Announcement
  15. Pharmac makes access to Estradiol TDP Mylan (oestradiol) patches easier for New Zealanders

    Pharmac is making it easier for people to access oestradiol treatment, by making it easier and more convenient for people to use the Estradiol TDP Mylan brand of patches.

    Announcement Safety
  16. 2025/26 Pharmac Letter of Expectations progress update | July 2026

    The Minister identified 13 expectations across three themes for Pharmac in his 2025/26 Letter of Expectations. This report tracks our progress on delivering to these expectations.

    Announcement Safety
  17. Agenda for September 2026 Immunisation Advisory Committee (IAC) meeting

    Information on what the Immunisation Advisory Committee (IAC) will be considering at its upcoming meeting in September 2026.

    Announcement Safety
  18. Prioritisation activity in the June quarter

    Pharmac’s Prioritisation Update provides the latest information about applications for medicines, vaccines, and related products that we’ve assessed for funding. Proactively releasing this informat...

    Announcement Safety
  19. Widened access to diabetes medicines to benefit over 30,000 New Zealanders

    From 1 September, Pharmac will widen access to four funded medicines for people with type 2 diabetes, making them available to over 30,000 more New Zealanders over the next five years.

    Announcement Safety
  20. Pharmac to refresh patient advisory function

    Pharmac is refreshing its patient advisory function as part of work to strengthen how patient voices and lived experience inform its decisions.

    Announcement Safety
  21. More people to access cholesterol-lowering medicine

    Announcement Safety
  22. Pharmac introduces a new vision and strategic priorities

    It has been a significant 12 months. We have taken the time to listen to patients, partners, and each other, to shape a new vision for Pharmac: Healthier futures. With you. For you.

    Announcement
  23. New agreement to save hospitals millions

    Pharmac has secured an ongoing supply of drug-eluting stents for public hospitals at a great price following a competitive procurement process.

    Announcement Safety

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.